| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 10/22/2002 | CA2185712C Enhanced virus-mediated dna transfer |
| 10/17/2002 | WO2002036605A9 Estrone-derivatives having cytoprotective activity |
| 10/17/2002 | US20020151532 Estrenes |
| 10/16/2002 | EP1248627A2 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 10/16/2002 | EP1248626A2 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 10/15/2002 | CA2038985C Haloethyl-substituted steroidal enzyme inhibitors |
| 10/10/2002 | WO2002078831A1 Method for the rapid thermal activation of a chemical reaction in a supercritical fluid solution |
| 10/10/2002 | WO2002078682A2 Estrogen replacement therapy |
| 10/10/2002 | WO2002078680A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 10/10/2002 | US20020147183 Angiogenesis inhibitors; antitumor agents, rheumatic diseases |
| 10/10/2002 | CA2441252A1 Estrogen replacement therapy |
| 10/10/2002 | CA2439842A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 10/09/2002 | EP1247566A1 Process for fast thermal excitation of a chemical reaction in a supercritical fluid solution |
| 10/09/2002 | EP1246604A1 Use of orally administered dehydroepiandrosterone, precursors and derivatives thereof in order to improve the papery aspect of the skin |
| 10/09/2002 | EP1246603A1 Oral use of dehydroepiandrosterone and some of its derivatives as pigmentation regulators |
| 10/09/2002 | EP0986573B1 Non-estrogenic estradiol derivatives with an antioxidant effect |
| 10/09/2002 | CN1373138A Androsterol bis (ethyl carbonate) ester compounds and preparing process thereof |
| 10/08/2002 | US6462182 Chemotherapy, microbial infections; enhanced solubility; catalysis, hydrolysis |
| 10/03/2002 | WO2002076465A1 Oestrogen and fatty acid monoester as a hypolipidaemic and antidiabetic agent |
| 10/03/2002 | WO2002076435A2 Lipid profile modulation with steroids |
| 10/03/2002 | WO2002076390A2 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 10/03/2002 | US20020143199 Method of producing steroid derivatives |
| 10/03/2002 | US20020143002 Estradiol-16alpha-carboxylic acid esters as locally active estrogens |
| 10/03/2002 | US20020143001 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 10/03/2002 | CA2441890A1 Oestrogen and fatty acid monoester as a hypolipidaemic and antidiabetic agent |
| 10/02/2002 | EP0944644B1 PROCESSES FOR PREPARATION OF 3-KETO-7alpha-ALKOXYCARBONYL-delta-4,5- STEROIDS AND INTERMEDIATES USEFUL THEREIN |
| 10/02/2002 | CN1372565A Non-aromatic estrogenic steroids with hydrocarbon substituent in position 11 |
| 10/01/2002 | US6458778 Estradienes |
| 09/26/2002 | WO2002022645A3 Method of making 7alpha-methyl-11beta-methoxy estradiol and related compounds with estrogenic activity |
| 09/25/2002 | EP1242094A1 Methods for treating mild cognitive impairment |
| 09/25/2002 | CN1370780A New organic compound 4-androstene-3beta, 17 beta-diol bis (ethylcarbonyldioxy) ester and its prepn |
| 09/19/2002 | WO2002072003A2 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour |
| 09/19/2002 | CA2440973A1 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour |
| 09/18/2002 | EP1240179A2 3-methylene steroid derivatives for the treatment of autoimmune diseases |
| 09/18/2002 | EP0891962B1 Process for the preparation of fluorinated dicarbonyl compounds |
| 09/18/2002 | EP0823889B1 1,3-propane diol derivatives as bioactive compounds |
| 09/17/2002 | US6451780 Progesterone antagonists for the production of pharmaceutical agents for the treatment of dysfunctional uterine bleeding |
| 09/17/2002 | CA2180325C Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
| 09/12/2002 | WO2002069977A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/12/2002 | WO2002038582A3 Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes |
| 09/12/2002 | WO2002038581A3 Method for the production of 4-(17alpha-methyl substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes |
| 09/12/2002 | CA2439687A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/11/2002 | EP1237903A1 11-beta-phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, production thereof and pharmaceutical compositions containing these compounds |
| 09/11/2002 | CN1090481C Estrogen/progestion-antiprogestin application its composition and medicine box |
| 08/29/2002 | WO2002000619A3 Alkyl ether modified polycyclic compounds having a terminal phenol as cell protecting agents |
| 08/29/2002 | US20020119959 Estrogenic compounds as anti-mitotic agents |
| 08/28/2002 | EP1131336B1 Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 |
| 08/27/2002 | US6440954 Inhibition of vascular smooth muscle cell proliferation |
| 08/27/2002 | US6440747 Stabilization of biological fluids by addition of sterol esters |
| 08/22/2002 | WO2002064614A1 Methods for preparing 7alpha-hydroxy-dehydroepiandrosterone |
| 08/21/2002 | EP1231924A2 Treatment of systemic lupus erythematosus (sle) with dehydroepiandrosterone |
| 08/21/2002 | EP0750501B1 Combined hormonal contraception pharmaceutical preparation |
| 08/21/2002 | EP0637203B1 Regulation of the immune system |
| 08/21/2002 | CN1089245C Soy extract, process for its prepn. and pharmaceutical compsn. |
| 08/20/2002 | US6437158 Testosterone derivative |
| 08/20/2002 | US6436917 Non-estrogenic estradiol derivative compounds with anti-oxidative activity |
| 08/20/2002 | US6436913 Use of estramustine phosphate in the treatment of bone metastasis |
| 08/15/2002 | WO2002062302A2 Steroidal derivatives |
| 08/15/2002 | CA2438221A1 Steroidal derivatives |
| 08/14/2002 | EP1189922A4 Steroid derivatives |
| 08/13/2002 | US6432940 Uses for androst-5-ene-3β, 17β-diol |
| 08/08/2002 | US20020107233 Useful for treating hypocholesterolemia |
| 08/08/2002 | US20020107229 Multistage preparation for contraception: 2-4 first stage daily dosage including a natural estrogen, form 16-22 second stage daily dosage portions including a natural or synthetic gestogen and a natural estrogen, and a specific third dosage |
| 08/08/2002 | US20020107209 Administering soyasaponin Bb; polycystic kidney disease; extracting soyasaponins from soybeans; nutraceuticals |
| 08/07/2002 | EP1228083A2 Therapeutic treatment of androgen receptor driven conditions |
| 08/07/2002 | EP1039912B1 Angiostatic agents and compositions for treating glc1a glaucoma |
| 08/01/2002 | WO2002059139A1 Androgenic 7-substituted 11-halogen steroids |
| 08/01/2002 | WO2002058634A2 ESTRADIOL-16α-CARBOXYLIC ACID ESTERS AS LOCALLY ACTIVE ESTROGENS |
| 08/01/2002 | US20020103391 17-methyleneandrost-4-en-3 alpha-ol for example; anxiolytic agents; ligand semiochemicals which bind to neuroepithelial receptors |
| 08/01/2002 | US20020103178 Administering steriods (e.g. estrogens), wherein a non-fused polycyclic, hydrophobic substituent such as adamantanyl is attached to the hydroxy-substituted A-ring thereof |
| 08/01/2002 | US20020103177 E.g. 7alpha,11beta-dimethyl-17beta-hydroxyestr-4-en-3-one; controlling male fertility; stereospecific synthesis starting from adrenosterone, and introducing the 7alpha substituent prior to an 11-substituent |
| 07/31/2002 | EP1226155A2 18-nor-steroids as selectively active estrogens |
| 07/31/2002 | EP1226154A1 Estradiol conjugates and uses thereof |
| 07/25/2002 | WO2001064193A3 Exemestane for first-line treatment of breast cancer |
| 07/25/2002 | DE10104327A1 New 11beta-halo-testosterone derivatives useful in male hormone replacement therapy and in male fertility control |
| 07/24/2002 | EP1224204A1 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 07/24/2002 | EP1223941A2 Therapeutic treatments comprising administratoin of certain steroids for blood cell deficiencies |
| 07/24/2002 | CN1360589A Orally active androgens |
| 07/23/2002 | US6423701 Water soluble amine esters of testosterone for intranasal administration |
| 07/23/2002 | US6423700 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 07/23/2002 | US6423698 Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia |
| 07/17/2002 | EP1223174A2 Processes for preparation of 3-keto-7alpha-alkoxycarbonyl-delta-4,5- steroids and intermediates useful therein |
| 07/17/2002 | EP1222459A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 07/17/2002 | EP1221933A2 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 07/16/2002 | US6420353 Use of 7 α-substituted steroid to treat neuropsychiatric, immune or endocrine disorders |
| 07/11/2002 | WO2002036605A3 Estrone-derivatives having cytoprotective activity |
| 07/11/2002 | WO2002028880A8 Compounds useful for treating hypertriglyceridemia |
| 07/11/2002 | WO2001010430A9 Use of estrogen compounds for prevention and treatment of ischemic damage |
| 07/09/2002 | US6417224 Prophylactic, therapeutic agent for osteoporosis |
| 07/03/2002 | EP1219632A1 Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds |
| 07/03/2002 | EP1219631A1 Antiandrogen agents |
| 07/03/2002 | EP1218516A2 Method for preparing steroids modified by yeast fermentation |
| 07/03/2002 | CN1357003A 类固醇衍生物 Steroid derivatives |
| 06/27/2002 | US20020082433 For therapy of disease states characterized by abnormal cell mitosis and abnormal angiogenesis |
| 06/26/2002 | CN1355809A Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 06/25/2002 | US6410523 Vitamin D derivatives substituted at the 2beta-position |
| 06/20/2002 | WO2002048169A1 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile |
| 06/20/2002 | WO2002047692A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis |
| 06/20/2002 | WO2002026759A3 17α FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 06/20/2002 | CA2431328A1 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile |